U.S. market Closed. Opens in 22 hours 49 minutes

TOIIW | The Oncology Institute, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue324.24M252.48M203.00M187.51M155.41M113.16M
Cost of Revenue264.67M200.39M162.16M150.64M125.46M86.88M
Gross Profit59.57M52.09M40.85M36.88M29.94M26.28M
Operating Expenses136.59M124.10M86.71M45.07M32.59M21.49M
Selling, General & Admin113.85M119.69M83.36M41.90M29.64M20.39M
Research & DevelopmentN/AN/AN/AN/AN/AN/A
Other Operating Expenses22.74M4.41M3.34M3.18M2.94M1.10M
Operating Income-77.02M-72.01M-45.86M-8.20M-2.63M4.79M
Other Expenses / Income-6.09M81.86M34.26M-6.62M6.62K71.17K
Before Tax Income-83.10M1.90M-11.60M-14.81M-2.64M4.86M
Income Tax Expenses-36.00K247.00K-671.00K-492.82K1.38M912.75K
Net Income-83.07M1.66M-10.93M-14.32M-4.02M3.95M
Interest Expenses6.78M4.08M320.00K347.06K3.38K1.59K
Basic Shares Outstanding73.75M72.79M66.23M59.12M64.45M28.75M
Diluted Shares Outstanding73.75M80.61M66.23M59.12M64.45M28.75M
EBITDA-70.45M8.40M-7.94M-11.29M307.11K9.08M
EBITDA Margin-21.73%3.33%-3.91%-6.02%0.20%8.02%
EBIT-76.33M5.99M-11.28M-14.47M-2.63M4.86M
EBIT Margin-23.54%2.37%-5.56%-7.72%-1.70%4.30%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙